A 51-year-old housewife presented with a history of fever, muscular weakness, morning cough, dyspnea, and back pain. She had been diagnosed with sarcoidosis for 8 years and was treated with prednisolone and azathioprine. On examination, evidence of multisystem involvement with sarcoidosis was found. Initial laboratory findings revealed inflammation (erythrocyte sedimentation rate, 41 mm/h; reference range, <20 mm/h), hypercalcemia (serum calcium, 15.7 mg/dL; reference range, 8.6-10.2 mg/ dL), hypercalciuria (urinary calcium, 305 mg/24 hours; reference range, 100-250 mg/24 hours), and thrombocytosis (platelet count, 463,000/μL; reference range, 150,000-450,000/μL). Serum phosphorus (2.7 mg/dL; reference range, 2.5-5 mg/dL), alkaline phosphatase (264 IU/L; reference range, 64-306 IU/L), and 24-hour urinary creatinine (588 mg/24 hours; reference range, 600-1800 mg/ 24 hours) were all within the normal limits.Hypercalcemia could be caused by malignancies, primary hyperparathyroidism, familial hypocalciuric hypercalcemia, and granulomatous diseases. 1 In fact, patients with sarcoidosis were reported to develop hypercalcemia due to various causes including hyperparathyroidism, inappropriate parathyroid hormone-related peptide production, elevated 1,25-dihydroxy vitamin D3 production, and renal insufficiency. 2,3 Therefore, measurement of serum parathyroid hormone (PTH) and 25-OH vitamin D3 levels was recommended. Provided that no aberrations in the 25-OH vitamin D3 level (29.3 ng/mL; reference range, 20-100 ng/mL) were observed, the patient's elevated PTH level (257 ng/mL; reference range, 10-65 ng/mL) confirmed hyperparathyroidism as the From the